128 related articles for article (PubMed ID: 34469833)
1. Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents.
Silva TB; Ji KNK; Petzold Pauli F; Galvão RMS; Faria AFM; Bello ML; Resende JALC; Campos VR; Forezi LDSM; da Silva FC; Faria RX; Ferreira VF
Bioorg Chem; 2021 Nov; 116():105250. PubMed ID: 34469833
[TBL] [Abstract][Full Text] [Related]
2. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV
Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742
[TBL] [Abstract][Full Text] [Related]
3. Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.
Papadopoulou MV; Bloomer WD; Lepesheva GI; Rosenzweig HS; Kaiser M; Aguilera-Venegas B; Wilkinson SR; Chatelain E; Ioset JR
J Med Chem; 2015 Feb; 58(3):1307-19. PubMed ID: 25580906
[TBL] [Abstract][Full Text] [Related]
4. Research for new antichagasic drugs.
Mester B; Claramunt RM; Elguero J; Atienza J; Gómez Barrio A; Escario JA
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):1990-3. PubMed ID: 1797419
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, activity, and molecular modeling studies of 1,2,3-triazole derivatives from natural phenylpropanoids as new trypanocidal agents.
de Souza TB; Caldas IS; Paula FR; Rodrigues CC; Carvalho DT; Dias DF
Chem Biol Drug Des; 2020 Jan; 95(1):124-129. PubMed ID: 31569301
[TBL] [Abstract][Full Text] [Related]
6. 3-Nitrotriazole-based piperazides as potent antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M
Eur J Med Chem; 2015 Oct; 103():325-34. PubMed ID: 26363868
[TBL] [Abstract][Full Text] [Related]
7. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
8. Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.
Papadopoulou MV; Trunz BB; Bloomer WD; McKenzie C; Wilkinson SR; Prasittichai C; Brun R; Kaiser M; Torreele E
J Med Chem; 2011 Dec; 54(23):8214-23. PubMed ID: 22023653
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.
Benaim G; Sanders JM; Garcia-Marchán Y; Colina C; Lira R; Caldera AR; Payares G; Sanoja C; Burgos JM; Leon-Rossell A; Concepcion JL; Schijman AG; Levin M; Oldfield E; Urbina JA
J Med Chem; 2006 Feb; 49(3):892-9. PubMed ID: 16451055
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M; Chatelain E; Ioset JR
Bioorg Med Chem; 2015 Oct; 23(19):6467-76. PubMed ID: 26344593
[TBL] [Abstract][Full Text] [Related]
11. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Kaiser M
Eur J Med Chem; 2014 Nov; 87():79-88. PubMed ID: 25240098
[TBL] [Abstract][Full Text] [Related]
12. Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Ashworth R; Wilkinson SR; Kaiser M; Andriani G; Rodriguez A
Future Med Chem; 2013 Oct; 5(15):1763-76. PubMed ID: 24144412
[TBL] [Abstract][Full Text] [Related]
13. Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Chatelain E; Kaiser M; Wilkinson SR; McKenzie C; Ioset JR
J Med Chem; 2012 Jun; 55(11):5554-65. PubMed ID: 22550999
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi.
Brand S; Ko EJ; Viayna E; Thompson S; Spinks D; Thomas M; Sandberg L; Francisco AF; Jayawardhana S; Smith VC; Jansen C; De Rycker M; Thomas J; MacLean L; Osuna-Cabello M; Riley J; Scullion P; Stojanovski L; Simeons FRC; Epemolu O; Shishikura Y; Crouch SD; Bakshi TS; Nixon CJ; Reid IH; Hill AP; Underwood TZ; Hindley SJ; Robinson SA; Kelly JM; Fiandor JM; Wyatt PG; Marco M; Miles TJ; Read KD; Gilbert IH
J Med Chem; 2017 Sep; 60(17):7284-7299. PubMed ID: 28844141
[TBL] [Abstract][Full Text] [Related]
16. 'Click chemistry' synthesis of a library of 1,2,3-triazole-substituted galactose derivatives and their evaluation against Trypanosoma cruzi and its cell surface trans-sialidase.
Carvalho I; Andrade P; Campo VL; Guedes PM; Sesti-Costa R; Silva JS; Schenkman S; Dedola S; Hill L; Rejzek M; Nepogodiev SA; Field RA
Bioorg Med Chem; 2010 Apr; 18(7):2412-27. PubMed ID: 20335038
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Antitrypanosomal Activity of 1,4-Disubstituted Triazole Compounds Based on a 2-Nitroimidazole Scaffold: a Structure-Activity Relationship Study.
Assunção ELF; Carvalho DB; das Neves AR; Kawasoko Shiguemotto CY; Portapilla GB; de Albuquerque S; Baroni ACM
ChemMedChem; 2020 Nov; 15(21):2019-2028. PubMed ID: 32729242
[TBL] [Abstract][Full Text] [Related]
18. Searching for new drugs for Chagas diseases: triazole analogs display high in vitro activity against Trypanosoma cruzi and low toxicity toward mammalian cells.
Faria RX; Gonzaga DTG; Pacheco PAF; Souza ALA; Ferreira VF; da Silva FC
J Bioenerg Biomembr; 2018 Apr; 50(2):81-91. PubMed ID: 29473131
[TBL] [Abstract][Full Text] [Related]
19. Anti-
Menozzi CAC; França RRF; Luccas PH; Baptista MDS; Fernandes TVA; Hoelz LVB; Sales Junior PA; Murta SMF; Romanha A; Galvão BVD; Macedo MO; Goldstein ADC; Araujo-Lima CF; Felzenszwalb I; Nonato MC; Castelo-Branco FS; Boechat N
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005183
[TBL] [Abstract][Full Text] [Related]
20. New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
Leite DI; Fontes FV; Bastos MM; Hoelz LVB; Bianco MDCAD; de Oliveira AP; da Silva PB; da Silva CF; Batista DDGJ; da Gama ANS; Peres RB; Villar JDF; Soeiro MNC; Boechat N
Chem Biol Drug Des; 2018 Sep; 92(3):1670-1682. PubMed ID: 29745048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]